Core Viewpoint - The announcement details the stock listing related to the equity incentive plan of Sino Medical Science Technology Co., Ltd., including the number of shares, listing date, and the decision-making process for the stock allocation [2][3][15]. Group 1: Stock Listing Details - The type of stock listing is for equity incentive shares, with a total of 1,904,000 shares to be listed [2]. - The listing date for the shares is set for January 22, 2026 [3][13]. - The shares are part of the 2022 restricted stock incentive plan, with the first allocation of the second vesting period recently completed [3][9]. Group 2: Decision-Making Process - The decision-making process for the stock allocation involved multiple meetings of the board and supervisory board, with independent directors providing clear consent [4][6][8]. - The company conducted a public notice period for the proposed incentive recipients, during which no objections were raised by employees [5][6]. Group 3: Stock Allocation and Impact - A total of 7 individuals will receive the allocated shares [12]. - The new shares will increase the total share capital from 416,048,000 to 417,952,000 shares, representing approximately 0.4576% of the total shares before the allocation [14][15]. - The allocation is not expected to have a significant impact on the company's recent financial status or operating results [15].
赛诺医疗科学技术股份有限公司 关于公司2022年限制性股票激励计划首次授予部分 第三个归属期第二次归属结果暨股份上市流通的公告